regulatory
confidence high
sentiment negative
materiality 0.70
Phunware, Inc. (PHUN): Nasdaq/NYSE listing notice — Phunware receives Nasdaq notice re audit committee noncompliance after director resignation; cure period until Dec 2024
Phunware, Inc.
- Nasdaq notified Phunware that audit committee lacks third independent member due to resignation of director Ryan Costello.
- Audit committee now has two members: Stephen Chen and Rahul Mewawalla, both independent but insufficient under Nasdaq Rule 5605.
- Cure period expires earlier of next annual meeting or Dec 31, 2024; if meeting before June 28, 2024, then cure deadline June 28.
- Failure to regain compliance may lead to delisting; Company is reviewing options but cannot assure compliance.